NCT05734053 - Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line | Biotech Hunter

Enrollment

222

Participants

Timeline

Start Date

June 28, 2016

Primary Completion Date

September 8, 2022

Study Completion Date

September 8, 2022

Conditions

Chronic Myeloid Leukemia

Interventions

OTHER

Nilotinib

There was no treatment allocation. Patients administered Nilotinib by prescription could be enrolled.

Trial Locations (77)

10709

Novartis Investigative Site, Berlin

12487

Novartis Investigative Site, Berlin

13055

Novartis Investigative Site, Berlin

14467

Novartis Investigative Site, Potsdam

15236

Novartis Investigative Site, Frankfurt (Oder)

20259

Novartis Investigative Site, Hamburg

21465

Novartis Investigative Site, Reinbek

24534

Novartis Investigative Site, Neumünster

26389

Novartis Investigative Site, Wilhelmshaven

26655

Novartis Investigative Site, Westerstede

27239

Novartis Investigative Site, Twistringen

27356

Novartis Investigative Site, Rotenburg (Wümme)

30161

Novartis Investigative Site, Hanover

30171

Novartis Investigative Site, Hanover

31135

Novartis Investigative Site, Hildesheim

31785

Novartis Investigative Site, Hamelin

32105

Novartis Investigative Site, Bad Salzuflen

32457

Novartis Investigative Site, Porta Westfalica

32657

Novartis Investigative Site, Lemgo

33604

Novartis Investigative Site, Bielefeld

37073

Novartis Investigative Site, Göttingen

38440

Novartis Investigative Site, Wolfsburg

38642

Novartis Investigative Site, Goslar

38820

Novartis Investigative Site, Halberstadt

41464

Novartis Investigative Site, Neuss

45468

Novartis Investigative Site, Viersen

47441

Novartis Investigative Site, Moers

48527

Novartis Investigative Site, Nordhorn

48683

Novartis Investigative Site, Ahaus

49076

Novartis Investigative Site, Osnabrück

50677

Novartis Investigative Site, Cologne

52064

Novartis Investigative Site, Aachen

52222

Novartis Investigative Site, Stolberg

56564

Novartis Investigative Site, Neuwied

58095

Novartis Investigative Site, Hagen

58644

Novartis Investigative Site, Iserlohn

59063

Novartis Investigative Site, Hamm

60398

Novartis Investigative Site, Frankfurt

60596

Novartis Investigative Site, Frankfurt

63739

Novartis Investigative Site, Aschaffenburg

64711

Novartis Investigative Site, Erbach im Odenwald

65191

Novartis Investigative Site, Wiesbaden

65428

Novartis Investigative Site, Rüsselsheim am Main

67346

Novartis Investigative Site, Speyer

71636

Novartis Investigative Site, Ludwigsburg

72250

Novartis Investigative Site, Freudenstadt

73614

Novartis Investigative Site, Schorndorf

74072

Novartis Investigative Site, Heilbronn

74078

Novartis Investigative Site, Heilbronn

77652

Novartis Investigative Site, Offenburg

78224

Novartis Investigative Site, Singen

80331

Novartis Investigative Site, München

80797

Novartis Investigative Site, Munich

84028

Novartis Investigative Site, Landshut

84503

Novartis Investigative Site, Altötting

86152

Novartis Investigative Site, Augsburg

86609

Novartis Investigative Site, Donauwörth

87700

Novartis Investigative Site, Memmingen

88400

Novartis Investigative Site, Biberach

89522

Novartis Investigative Site, Baden-Württemberg

90403

Novartis Investigative Site, Nuremberg

90449

Novartis Investigative Site, Nuremberg

95445

Novartis Investigative Site, Bayreuth

96049

Novartis Investigative Site, Bamberg

96317

Novartis Investigative Site, Kronach

96450

Novartis Investigative Site, Coburg

97080

Novartis Investigative Site, Würzburg

97980

Novartis Investigative Site, Bad Mergentheim

99084

Novartis Investigative Site, Erfurt

99085

Novartis Investigative Site, Erfurt

08301

Novartis Investigative Site, Bad Schlema

01127

Novartis Investigative Site, Dresden

02763

Novartis Investigative Site, Zittau

04924

Novartis Investigative Site, Bad Liebenwerda

07548

Novartis Investigative Site, Gera

06110

Novartis Investigative Site, Halle

06217

Novartis Investigative Site, Merseburg